#insilico — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #insilico, aggregated by home.social.
-
K-Bio Courts Big Pharma With AI; Celltrion Books 150 Meetings
“After Cenobamate, our epilepsy treatment, was commercialized, one of the answers we reached after agonizing over how to…
#EuropeSays #Korea #KR #SamsungBiologics #AIdrugdevelopment #AstraZeneca #BIOUSA2026 #Celltrion #Galux #Insilico #Samsung #SKBiopharmaceuticals
https://www.europesays.com/korea/62825/ -
K-Bio Courts Big Pharma With AI; Celltrion Books 150 Meetings
“After Cenobamate, our epilepsy treatment, was commercialized, one of the answers we reached after agonizing over how to…
#EuropeSays #Korea #KR #SamsungBiologics #AIdrugdevelopment #AstraZeneca #BIOUSA2026 #Celltrion #Galux #Insilico #Samsung #SKBiopharmaceuticals
https://www.europesays.com/korea/62229/ -
Insilico Medicine has signed a global licensing deal worth up to 2.75 billion USD with Eli Lilly for an AI-discovered oral GLP-1 drug. The Hong Kong-listed AI drug discovery company received 115 million USD upfront and reported 2025 revenue of 56.2 million USD, with its drug discovery segment growing 693.6% year-over-year. https://pandaily.com/insilico-medicine-signs-2-75-b-deal-with-eli-lilly #China #Tech #AI #Insilico
-
Insilico Medicine has signed a global licensing deal worth up to 2.75 billion USD with Eli Lilly for an AI-discovered oral GLP-1 drug. The Hong Kong-listed AI drug discovery company received 115 million USD upfront and reported 2025 revenue of 56.2 million USD, with its drug discovery segment growing 693.6% year-over-year. https://pandaily.com/insilico-medicine-signs-2-75-b-deal-with-eli-lilly #China #Tech #AI #Insilico
-
#EliLilly and #Insilico Medicine have signed a $2.75 billion deal to bring #AIdeveloped #drugs to the global market. The agreement includes upfront payments, milestone payments, and royalties, and builds on their existing collaboration. https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html?eicker.news #tech #media #news
-
#EliLilly and #Insilico Medicine have signed a $2.75 billion deal to bring #AIdeveloped #drugs to the global market. The agreement includes upfront payments, milestone payments, and royalties, and builds on their existing collaboration. https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html?eicker.news #tech #media #news
-
Il y a des projets auxquels j'ai participé et / ou donné mon avis professionnel qui ne décollent pas, et dont la dénomination se diffuse dans le "domaine public" : les clients potentiels ont des attentes non-dites...
#BioInformatique #InVivo #InVitro #InSilico #JumeauNumérique
-
Efforts to reduce animal experiments are important and should be pursued. But despite progress in #AI, #organoids, and #InSilico models, I’m not convinced we’re there yet — especially in #neuroscience, where #complexity and systemic #context matter. However, I do think we should stay committed and aim for reduction by all available means. I recently came across this article, which gives a good overview of the current state of the field:
-
#introduction Associate Prof in #medical #computational engineering at University of Leeds, interest in #musculoskeletal #biomechanics and using combined #invitro and #insilico methods to understand how everyone's joint is different, and how to use that knowledge in developing and testing repair devices.
-
@academicchatter @academicsunite Dear all. Anybody working with the #computational side of #environmental #biotechnology ? We try to devise #bioinformatics approach to investigates human coagulation factor II that is responsible for blod clotting as a possible method for water treatment against gram negative #bacteria (GNB). We tap in into the possibilities whether factor II could hydrolyse GNB in this #insilico implementations. You can check the paper in here: https://zenodo.org/record/5219013#.Y3Lo7uxBxQJ 🙂
-
@academicchatter @academicsunite Dear all. Anybody working with the #computational side of #environmental #biotechnology ? We try to devise #bioinformatics approach to investigates human coagulation factor II that is responsible for blod clotting as a possible method for water treatment against gram negative #bacteria (GNB). We tap in into the possibilities whether factor II could hydrolyse GNB in this #insilico implementations. You can check the paper in here: https://zenodo.org/record/5219013#.Y3Lo7uxBxQJ 🙂